a system for gene delivery that is adaptable to in vivo-scale HBV therapies, with no significant toxicity
This knockdown was noticed for all scAAV-treated samples, indicating that infection with the scAAV vector irrespective of its payload has an inhibitory impact on HBV. In a scientific setting, cccDNA…